In the study conducted by Schoretsanitis and colleagues, what was a key finding regarding semaglutide-associated suicidal ADRs in relation to concomitant use of antidepressants or benzodiazepines? A. The presence of antidepressants or benzodiazepines reduced the risk of semaglutide-associated suicidal ADRs.B. Disproportionality for semaglutide-associated suicidal ideation remained significant only when antidepressants and benzodiazepines were excluded.C. Suicidality and suicidal ideation were observed only in patients using semaglutide without any concomitant medications.D. The signal for semaglutide-associated suicidal ideation remained significant when antidepressants or benzodiazepines were used.
[Verified Answer]: In the study conducted by Schoretsanitis…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.